BD Partner/Investor Presentation

Summary

SciVida assisted an early-stage biotech company in articulating the market potential and commercial story for its lead product candidate for engaging with external stakeholders in prospective partnership/investor discussions.

Situation

Our client, an emerging biotech with several assets in preclinical and clinical development, was nearing Phase 2 on its lead candidate and preparing to engage in partner/investor discussions. The asset was an innovative and targeted disease-modifying therapy for a historically mismanaged condition, and the client needed help explaining the complex disease landscape and crafting a compelling commercial story regarding the product’s potential value.

SciVida’s Approach

Our team began by facilitating a brainstorming workshop with the client’s leadership team to align on key requirements for the investor presentation as well as strategic imperatives within key areas to support commercial success.

SciVida combined output from the workshop with all previously completed relevant work and collaborated closely with the client to align on key needs for the investor presentation. The document was designed to include disease background, current treatment landscape, key unmet needs, the market size and opportunity, the asset’s value proposition, and a winning strategy for the client centered around their priority areas of regulatory approval, competitive differentiation, and market access.

We socialized a detailed outline with executives from the client team, refined the structure, and then developed the presentation.

Finally, our team iterated with the client’s senior leaders and board of directors to finalize the presentation, which was then immediately shared with prospective partners and investors.